Porphyria Cutanea Tarda in a Patient with End-Stage Renal Disease: A Case of Successful Treatment with Deferoxamine and Ferric Carboxymaltose
Table 1
Laboratory results.
Result
Reference
Haemoglobin
104 g/L
100–120 g/L
WBC count
6.06 × 109/L
3.8–10.8 × 109/L
Platelet count
138 × 109/L
150–450 × 109/L
C-reactive protein
0.04 mg/L
<0.8 mg/L
Transferrin saturation
43%
>30%
Ferritin
267 µg/L
200–500 µg/L
ALT
53 U/L
<20 U/L
AST
34 U/L
<42 U/L
G-GT
133 U/L
8–65 U/L
Total plasma porphyrin
1052.3 ug/L
<32.5 ug/L
Plasma uroporphyrin
983.3 ug/L
< 11.8 ug/L
Plasma heptacarboxylporphyrin
24.3 ug/L
<3.8 ug/L
Plasma hexacarboxylporphyrin
13.4 ug/L
<1.3 ug/L
Plasma pentacarboxylporphyrin
27.3 ug/L
<27.3 ug/L
Plasma coproporphyrin I
2.5 ug/L
<6.4 ug/L
Plasma coproporphyrin II
1.5 ug/L
<8 ug/L
Faecal porphyrins
All normal
Urinary porphyrins
Anuric
ALT, alanine aminotransferase; AST, aspartate aminotransferase; G-GT, gamma-glutamate transpeptidase. The reference values for haemoglobin, ferritin, and transferrin saturation are in concordance with KDIGO considering ESRD patients.